<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml2/DTD/xhtml1-strict.dtd">
<html><!-- #BeginTemplate "/Templates/ACA_Template.dwt" --><!-- DW6 -->
<head>
<!-- #BeginEditable "doctitle" -->
<title>Croquet Australia: WADA 2010 Prohibited List</title>



<!-- #EndEditable -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<link href="/CSS/ACA.css" rel="stylesheet" type="text/css" />

<!--[if IE 7]><style type="text/css">.menu li {float:left;}</style><![endif]-->
</head>

<body bgcolor="#FFFFFF" text="#000000">
<table width="100%" border="0">
  <tr> 
    <td width="150" valign="middle" align="center">
    	<a href="http://www.croquet-australia.com.au/"><img src="/small_ACA_Pocket_Logo.jpg" width="93" height="70" /></a>
    </td>
	<td colspan="3" class="tdback"><!-- #BeginEditable "Title Banner" -->
      <h1 align="center">WADA 2010 Prohibited List</h1>
    <!-- #EndEditable --></td>
  </tr>
  <tr> 
    <td valign="top"> 
      <script type="text/javascript" src="/Templates/LH_Nav_Bar.js">  </script>
	</td>
    <td colspan="3" valign="top"><!-- #BeginEditable "Main Text Body" -->
      <p class="style3"><font face="Times New Roman" size="3"><span style="font-size: 12pt;">WCF Notice<o:p><br />
      </o:p>1st October 2009<o:p></o:p></span></font></p>
      <div></div>
      <div></div>
      <div>        
        <p class="style3"><font face="Times New Roman" size="3"><span style="font-size: 12pt;">The&nbsp;World Anti-Doping Agency has published the 2010 Prohibited List of&nbsp;Prohibited Substances and Methods, which will take effect on January 1,&nbsp;2010.<o:p></o:p></span></font></p>
      </div>
      <div>        
        <p class="style3"><font face="Times New Roman" size="3"><span style="font-size: 12pt;">The&nbsp;Prohibited List is one of the cornerstones of the harmonised fight&nbsp;against doping. It specifies substances and methods prohibited in&nbsp;sport. Its&nbsp;implementation is mandatory for organizations that have&nbsp;adopted the World Anti-Doping Code.<br />
          <br />
      The World Croquet Federation has NOT adopted the Anti-Doping code, however the following affiliated organizations have:</span></font>
      </p>
        <ul>
          <li class="style3">
            <p><font size="3" face="Times New Roman"><span style="font-size: 12pt;"><st1:country-region w:st="on"><st1:place w:st="on">Australia</st1:place></st1:country-region> Croquet Association</span></font></p>
          </li>
          <li class="style3">
            <p><font size="3" face="Times New Roman"><span style="font-size: 12pt;">Croquet Association of <st1:country-region w:st="on"><st1:place w:st="on">Ireland</st1:place></st1:country-region></span></font></p>
          </li>
          <li class="style3">
            <p><font size="3" face="Times New Roman"><span style="font-size: 12pt;"><st1:country-region w:st="on"><st1:place w:st="on">New Zealand</st1:place></st1:country-region> Croquet Council</span></font></p>
          </li>
        </ul>
        <p class="style3"><font face="Times New Roman" size="3"><span style="font-size: 12pt;">All croquet matches played under their jurisdiction may result in an anti-Doping Test of the players concerned.<br />
          <br />
          Any&nbsp;player wishing to avail themselves of a Therapeutic Use Exemption (TUE)&nbsp;should contact the relevant croquet association for further advice.<br />
          <br />
                <u>Change of Status for Salbutamol</u><br />
          <br />
          The&nbsp;2010 List offers a number of changes compared to the 2009 List. In&nbsp;particular, the status of salbutamol, a beta-2 agonist, will change.&nbsp;Salbutamol &ndash; a substance considered as specified and therefore more&nbsp;likely to result in a sanction of a warning to a two-year ban in case&nbsp;of anti-doping rule violations &ndash; will be permitted under 1,000&nbsp;nanograms per millilitre. Under the 2010 List, its use by inhalation&nbsp;will no longer require TUE but&nbsp;rather a simplified declaration of use.&nbsp;This measure will allow the handling of salbutamol by anti-doping&nbsp;organizations in a more cost-efficient way.<br />
          <br />
          In&nbsp;addition, the 2010 List will no longer prohibit supplemental oxygen&nbsp;(hyperoxia). The status of platelet-derived preparations (e.g. Platelet&nbsp;Rich&nbsp;Plasma, &ldquo;blood spinning&rdquo;) has also been clarified. These&nbsp;preparations will be prohibited when administered by intramuscular&nbsp;route. Other routes of&nbsp;administration will require a declaration of use&nbsp;in compliance with the International Standard for TUEs.<br />
          <br />
                <u>Pseudoephedrine Reintroduced</u><br />
          <br />
          Another&nbsp;noteworthy amendment is the reintroduction of pseudoephedrine to the&nbsp;List as a specified stimulant &ndash; a category of substances that is more&nbsp;likely to result in a sanction of a warning to a two-year ban in case&nbsp;of anti-doping rule violations.<br />
          <br />
          Until&nbsp;2003, pseudoephedrine was prohibited in sport. Pseudoephedrine was&nbsp;subsequently included in WADA&rsquo;s Monitoring Program in 2004. The&nbsp;Monitoring Program includes substances that are not prohibited in sport&nbsp;but are monitored in order to detect patterns of misuse.<br />
          <br />
          Results&nbsp;of the Monitoring Program over the past five years have shown a&nbsp;sustained increase in samples containing pseudoephedrine concentrations&nbsp;of more than 75 micrograms per millilitre. The Program indicated clear&nbsp;abuse of this substance with high concentrations in a number of sports&nbsp;and&nbsp;regions. In addition, available literature shows scientific&nbsp;evidence of the performance-enhancing effects of pseudoephedrine beyond&nbsp;certain doses.<br />
          <br />
          Based&nbsp;on literature and results of controlled excretion studies funded by&nbsp;WADA, pseudoephedrine will therefore be reintroduced in the List&nbsp;starting on&nbsp;January 1, 2010, with a urinary threshold of 150&nbsp;micrograms per millilitre. Given the wide availability of medicines&nbsp;containing pseudoephedrine,&nbsp;WADA&rsquo;s Scientific Committees and Executive&nbsp;Committee recommended that the reintroduction of pseudoephedrine be&nbsp;accompanied by information&nbsp;and education campaigns by WADA&rsquo;s&nbsp;stakeholders.<br />
          <br />
                <a href="http://www.wada-ama.org/rtecontent/document/Additional_info_pseudoephedrine_2010_EN_Web.pdf">Advice regarding Pseudoephedrine</a><br />
          <br />
                <a href="http://www.wada-ama.org/rtecontent/document/2010_Prohibited_List_FINAL_EN_Web.pdf">The full 2010 Prohibited List</a><br />
          <br />
                <a href="http://www.wcfcroquet.org/Organisation/anti-doping.php">The WCF Anti-Doping pages</a></span></font></p>
      </div>
      <p class="style3">&nbsp;</p>
      <!-- #EndEditable --></td>
  </tr>

  <script type="text/javascript" src="/Templates/Footer.js">  </script>

</table>
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-4518381-2', 'croquet-australia.com.au');
  ga('send', 'pageview');

</script>

</body>
<!-- #EndTemplate --></html>
